Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD
- PMID: 34110904
- DOI: 10.1161/CIRCRESAHA.121.318261
Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD
Abstract
Effective revascularization of the patient with peripheral artery disease is about more than the procedure. The approach to the patient with symptom-limiting intermittent claudication or limb-threatening ischemia begins with understanding the population at risk and variation in clinical presentation. The urgency of revascularization varies significantly by presentation; from patients with intermittent claudication who should undergo structured exercise rehabilitation before revascularization (if needed) to those with acute limb ischemia, a medical emergency, who require revascularization within hours. Recent years have seen the rapid development of new tools including wires, catheters, drug-eluting technology, specialized balloons, and biomimetic stents. Open surgical bypass remains an important option for those with advanced disease. The strategy and techniques employed vary by clinical presentation, lesion location, and lesion severity. There is limited level 1 evidence to guide practice, but factors that determine technical success and anatomic durability are largely understood and incorporated into decision-making. Following revascularization, medical therapy to reduce adverse limb outcomes and a surveillance plan should be put in place. There are many hurdles to overcome to improve the efficacy of lower extremity revascularization, such as restenosis, calcification, microvascular disease, silent embolization, and tools for perfusion assessment. This review highlights the current state of revascularization in peripheral artery disease with an eye toward technologies at the cusp, which may significantly impact current practice.
Keywords: catheter; decision-making; intermittent claudication; peripheral arterial disease; risk factor.
Similar articles
-
Endovascular intervention for peripheral artery disease.Circ Res. 2015 Apr 24;116(9):1599-613. doi: 10.1161/CIRCRESAHA.116.303503. Circ Res. 2015. PMID: 25908731 Free PMC article. Review.
-
Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.Vasc Med. 2020 Dec;25(6):527-533. doi: 10.1177/1358863X20952856. Epub 2020 Oct 6. Vasc Med. 2020. PMID: 33019909
-
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.J Vasc Surg. 2015 Mar;61(3 Suppl):2S-41S. doi: 10.1016/j.jvs.2014.12.009. Epub 2015 Jan 28. J Vasc Surg. 2015. PMID: 25638515 Review.
-
In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.J Vasc Surg. 2019 Feb;69(2):482-489. doi: 10.1016/j.jvs.2018.06.207. Epub 2018 Oct 6. J Vasc Surg. 2019. PMID: 30301689 Free PMC article.
-
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.J Vasc Surg. 2016 Dec;64(6):1633-1644.e1. doi: 10.1016/j.jvs.2016.05.098. Epub 2016 Aug 27. J Vasc Surg. 2016. PMID: 27575814 Free PMC article.
Cited by
-
2024 TSOC/TSPS Joint Consensus: Strategies for Advanced Vascular Wound Management in Arterial and Venous Diseases.Acta Cardiol Sin. 2024 Jan;40(1):1-44. doi: 10.6515/ACS.202401_40(1).20231220A. Acta Cardiol Sin. 2024. PMID: 38264067 Free PMC article.
-
Postintervention monitoring of peripheral arterial disease wound healing using dynamic vascular optical spectroscopy.J Biomed Opt. 2022 Dec;27(12):125002. doi: 10.1117/1.JBO.27.12.125002. Epub 2022 Dec 24. J Biomed Opt. 2022. PMID: 36582192 Free PMC article.
-
Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections.Antibiotics (Basel). 2023 Mar 31;12(4):685. doi: 10.3390/antibiotics12040685. Antibiotics (Basel). 2023. PMID: 37107047 Free PMC article.
-
A one-two punch of inflammation and oxidative stress promotes revascularization for diabetic foot ulcers.Mater Today Bio. 2025 Feb 4;31:101548. doi: 10.1016/j.mtbio.2025.101548. eCollection 2025 Apr. Mater Today Bio. 2025. PMID: 39995578 Free PMC article.
-
Open and endovascular treatment of the common femoral artery in a tertiary care center.J Vasc Surg. 2025 Feb;81(2):386-396.e2. doi: 10.1016/j.jvs.2024.10.027. Epub 2024 Oct 22. J Vasc Surg. 2025. PMID: 39442735
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical